7.48
前日終値:
$7.26
開ける:
$7.43
24時間の取引高:
1.27M
Relative Volume:
1.07
時価総額:
$565.11M
収益:
$11.40B
当期純損益:
$-95.73M
株価収益率:
-3.0531
EPS:
-2.45
ネットキャッシュフロー:
$-64.37M
1週間 パフォーマンス:
+2.47%
1か月 パフォーマンス:
+7.94%
6か月 パフォーマンス:
-8.05%
1年 パフォーマンス:
-15.00%
Mind Medicine Inc Stock (MNMD) Company Profile
MNMD を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
MNMD
Mind Medicine Inc
|
7.48 | 539.45M | 11.40B | -95.73M | -64.37M | -2.45 |
![]()
ONC
Beone Medicines Ltd Adr
|
245.93 | 25.76B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
445.43 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.415 | 40.54M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
84.10 | 6.44B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
490.81 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-01-28 | 開始されました | Evercore ISI | Outperform |
2024-12-20 | 開始されました | Chardan Capital Markets | Buy |
2024-10-14 | 再開されました | Leerink Partners | Outperform |
2024-07-24 | 開始されました | ROTH MKM | Buy |
2024-05-29 | 開始されました | Robert W. Baird | Outperform |
2024-04-15 | 開始されました | Leerink Partners | Outperform |
2023-12-05 | 開始されました | Canaccord Genuity | Buy |
2022-12-09 | 再開されました | ROTH Capital | Buy |
2022-11-16 | 開始されました | RBC Capital Mkts | Outperform |
2022-08-26 | 開始されました | Oppenheimer | Outperform |
2022-08-10 | 開始されました | Cantor Fitzgerald | Overweight |
2022-05-04 | 開始されました | ROTH Capital | Buy |
2021-06-28 | 開始されました | Maxim Group | Buy |
すべてを表示
Mind Medicine Inc (MNMD) 最新ニュース
Wall Street Analysts Believe Mind Medicine MindMed (MNMD) Could Rally 237.47%: Here's is How to Trade - Nasdaq
MindMed Issues Inducement Grants to New Employees - TipRanks
MindMed Appoints Brandi Roberts as CFO to Drive Growth and Commercialization - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
MindMed (MNMD) Poised for Breakthrough in Anxiety Disorder Treat - GuruFocus
MindMed (MNMD) Poised for Breakthrough in Anxiety Disorder Treatment | MNMD Stock News - GuruFocus
Cantor Fitzgerald maintains Overweight rating on MindMed stock By Investing.com - Investing.com India
MindMed to Participate in June Investor Conferences | MNMD Stock News - GuruFocus
MindMed to Participate in June Investor Conferences - The Globe and Mail
MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer - StreetInsider
Mind Medicine (MNMD) Appoints Brandi Roberts as New CFO | MNMD S - GuruFocus
Mind Medicine Names Brandi Roberts CFO - marketscreener.com
Mindmed Strengthens Executive Team With Appointment Of Brandi Roberts As Chief Financial Officer - marketscreener.com
Mind Medicine Appoints New Chief Financial Officer - TipRanks
Mind Medicine (MNMD) Appoints Brandi Roberts as New CFO | MNMD Stock News - GuruFocus
MindMed appoints Brandi L. Roberts as CFO By Investing.com - Investing.com India
MindMed appoints Brandi L. Roberts as CFO - Investing.com Australia
2 ‘Strong Buy’ Psychedelic Stocks To Scoop Up ASAP - Barchart.com
MindMed Appoints Brandi Roberts, CPA, as Chief Financial Officer - citybiz
MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer | MNMD Stock News - GuruFocus
(MNMD) Trading Signals - news.stocktradersdaily.com
Analysts Set Expectations for MNMD Q1 Earnings - Defense World
FY2025 EPS Estimates for MNMD Cut by Cantor Fitzgerald - Defense World
Northern Trust Corp Has $4.77 Million Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
MindMed at RBC Conference: Progress in Psychedelic Therapies By Investing.com - Investing.com India
MindMed at RBC Conference: Progress in Psychedelic Therapies - Investing.com
Mind Medicine (MindMed) Inc. (MNMD): Analysts See 285% Upside Potential - Insider Monkey
MNMD Stock Rises Amid Connecticut's Psilocybin Decriminalization Bill - GuruFocus
Why Mind Medicine Stock Vaulted More Than 8% Higher Today - Yahoo
Mind Medicine (MNMD) Stocks Climb Amid FDA Focus on Psychedelics - GuruFocus
Psychedelic stocks up after FDA chief’s comments (ATAI:NASDAQ) - Seeking Alpha
13 Best Multibagger Stocks to Invest in Now - Insider Monkey
MindMed Announces New Employee Inducement Grants | MNMD Stock News - GuruFocus
MindMed Announces New Employee Inducement Grants - Business Wire
Price T Rowe Associates Inc. MD Acquires 8,361 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Was Jim Cramer Right About Mind Medicine (MNMD) Stock? - Insider Monkey
(MNMD) Technical Data - news.stocktradersdaily.com
Mind Medicine (MindMed) (NASDAQ:MNMD) Upgraded at Cantor Fitzgerald - Defense World
Analysts Offer Predictions for MNMD FY2025 Earnings - Defense World
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Rating of “Buy” by Analysts - Defense World
Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect? - MSN
Raymond James Financial Inc. Makes New $111,000 Investment in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
MindMed projects 2026 trial readouts for pivotal MM120 studies in GAD and MDD - MSN
MindMed to Present at the 2025 RBC Capital Markets Global Health - GuruFocus
MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference - The Joplin Globe
Mind Medicine (MindMed)’s (MNMD) “Buy” Rating Reiterated at Chardan Capital - Defense World
MindMed to Host Key Opinion Leader Webinar on Substance Use Diso - GuruFocus
Mind Medicine (MNMD) Rating and Price Target Maintained by Chard - GuruFocus
Psychedelic: Compass, GH Research, MindMed report quarterly earnings - Yahoo Finance
Rising Leaders 2025: Rob Barrow On Leading MindMed’s Psychedelic Renaissance - insights.citeline.com
Mind Medicine Inc (MNMD) Q1 2025 Earnings Call Highlights: Strategic Advances Amidst Financial ... - Yahoo Finance
Mind Medicine Inc (MNMD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):